Skip to main content
Premium Trial:

Request an Annual Quote

Roche: Jörg Duschmalé, Patrick Frost

Roche has elected Jörg Duschmalé and Patrick Frost to its board of directors, while Andreas Oeri and John Bell have stepped down after 24 and 19 years on the board, respectively. Oeri was the representative of the current shareholder pool.

Duschmalé is a fifth-generation descendant of Roche's founder, and he was a postdoctoral researcher in oligonucleotide chemistry at Roche from 2015 to 2018. Frost has worked at life insurance company Swiss Life in Zurich since 2006, first as Group Chief Information Office and now as Group CEO. He previously served as the global head of fixed income investment at Winterthur Insurance.
The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.